Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5398730, 9 pages
http://dx.doi.org/10.1155/2016/5398730
Research Article

Evaluation of Hepatotoxicity with Treatment Doses of Flucytosine and Amphotericin B for Invasive Fungal Infections

1Department of Pathology, Faculty of Medicine, “Vasile Goldis” Western University of Arad, 86 Rebreanu Street, 310414 Arad, Romania
2Department of Bioethics, Faculty of Medicine, “Vasile Goldis” Western University of Arad, 86 Rebreanu Street, 310414 Arad, Romania
3Institute of Life Sciences, Vasile Goldis Western University of Arad, 86 Rebreanu, 310414 Arad, Romania
4Faculty of Veterinary Medicine, Department of Chemistry, Biochemistry and Molecular Biology, Banat University of Agricultural Sciences and Veterinary Medicine “King Mihai I of Romania” Timisoara, 119 Calea Aradului, 300645 Timisoara, Romania
5Department of Biochemistry and Molecular Biology, University of Bucharest, 91-95 Splaiul Independentei, 050095 Bucharest, Romania
6Department of Histology, Faculty of Medicine, “Vasile Goldis” Western University of Arad, 86 Rebreanu Street, 310414 Arad, Romania

Received 16 September 2015; Revised 6 December 2015; Accepted 9 December 2015

Academic Editor: Bo Zuo

Copyright © 2016 Alexandra Folk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. G. Pappas, C. A. Kauffman, D. Andes et al., “Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 48, no. 5, pp. 503–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Klepser, “The value of amphotericin B in the treatment of invasive fungal infections,” Journal of Critical Care, vol. 26, no. 2, pp. 225.e1–225.e10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K. C. Gray, D. S. Palacios, I. Dailey et al., “Amphotericin primarily kills yeast by simply binding ergosterol,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 7, pp. 2234–2239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Wilson, L. Thorson, and D. P. Speert, “Enhancement of macrophage superoxide anion production by amphotericin B,” Antimicrobial Agents and Chemotherapy, vol. 35, no. 5, pp. 796–800, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Vermes, H.-J. Guchelaar, and J. Dankert, “Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions,” Journal of Antimicrobial Chemotherapy, vol. 46, no. 2, pp. 171–179, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. J. E. Bennett, W. E. Dismukes, R. J. Duma et al., “A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis,” The New England Journal of Medicine, vol. 301, no. 3, pp. 126–131, 1979. View at Publisher · View at Google Scholar · View at Scopus
  7. M. S. Saag, R. J. Graybill, R. A. Larsen et al., “Practice guidelines for the management of cryptococcal disease,” Clinical Infectious Diseases, vol. 30, no. 4, pp. 710–718, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. D. A. Enoch, H. A. Ludlam, and N. M. Brown, “Invasive fungal infections: a review of epidemiology and management options,” Journal of Medical Microbiology, vol. 55, no. 7, pp. 809–818, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. L. Wang, C. H. Chang, Y. Y. Xu, and K. A. Chan, “Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 6, pp. 2409–2419, 2010. View at Publisher · View at Google Scholar
  10. N. Somchit, J. H. Chung, A. Yaacob, Z. Ahmad, Z. A. Zakaria, and A. A. Kadir, “Lack of hepato- and nephrotoxicity induced by antifungal drug voriconazole in laboratory rats,” Drug and Chemical Toxicology, vol. 35, no. 3, pp. 304–309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Soltani, C. M. Tobin, K. E. Bowker, J. Sunderland, A. P. MacGowan, and A. M. Lovering, “Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory,” International Journal of Antimicrobial Agents, vol. 28, no. 6, pp. 574–577, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Schwarz, F. Dromer, O. Lortholary, and E. Dannaoui, “Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 1, pp. 113–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔC(T) method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Austyn and S. Gordon, “F4/80, a monoclonal antibody directed specifically against the mouse macrophage,” European Journal of Immunology, vol. 11, no. 10, pp. 805–815, 1981. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. G. T. Rüping, J. J. Vehreschild, and O. A. Cornely, “Patients at high risk of invasive fungal infections: when and how to treat,” Drugs, vol. 68, no. 14, pp. 1941–1962, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. M. Markiewski, R. A. DeAngelis, and J. D. Lambris, “Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiologic processes?” Molecular Immunology, vol. 43, no. 1-2, pp. 45–56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. Weiss, “Cytokines in liver, biliary, and pancreatic disease,” in Blumgart's Surgery of the Liver, Pancreas and Biliary Tract, chapter 10, pp. 166–180, Saunders, 2012. View at Google Scholar
  18. L. Fredriksson, S. Wink, B. Herpers et al., “Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFα-mediated hepatotoxicity,” Toxicological Sciences, vol. 140, no. 1, pp. 144–159, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Choi, H.-S. Kang, Y. Yang, and K.-H. Pyun, “IL-6 induces hepatic inflammation and collagen synthesis in vivo,” Clinical and Experimental Immunology, vol. 95, no. 3, pp. 530–535, 1994. View at Google Scholar · View at Scopus
  20. C. A. Norris, M. He, L.-I. Kang et al., “Synthesis of IL-6 by hepatocytes is a normal response to common hepatic stimuli,” PLoS ONE, vol. 9, no. 4, Article ID e96053, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. B.-O. Cho, H.-W. Ryu, Y. So et al., “Hepatoprotective effect of 2,3-dehydrosilybin on carbon tetrachloride-induced liver injury in rats,” Food Chemistry, vol. 138, no. 1, pp. 107–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Xiao, E. C. Liong, Y. P. Ching et al., “Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury,” Nutrition and Diabetes, vol. 3, article e81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Pȩkalski, P. J. Zuk, M. Kochańczyk et al., “Spontaneous NF-κB activation by autocrine TNFα signaling: a computational analysis,” PLoS ONE, vol. 8, no. 11, Article ID e78887, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Lawrence, “The nuclear factor NF-κB pathway in inflammation,” Cold Spring Harbor Perspectives in Biology, vol. 1, Article ID a001651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. A. Roberts, P. E. Ganey, C. Ju, L. M. Kamendulis, I. Rusyn, and J. E. Klaunig, “Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis,” Toxicological Sciences, vol. 96, no. 1, pp. 2–15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Kolios, V. Valatas, and E. Kouroumalis, “Role of Kupffer cells in the pathogenesis of liver disease,” World Journal of Gastroenterology, vol. 12, no. 46, pp. 7413–7420, 2006. View at Google Scholar · View at Scopus